KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Current Assets (2016 - 2025)

Neogenomics (NEO) has disclosed Current Assets for 16 consecutive years, with $376.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 36.87% year-over-year to $376.3 million, compared with a TTM value of $376.3 million through Dec 2025, down 36.87%, and an annual FY2025 reading of $376.3 million, down 36.87% over the prior year.
  • Current Assets was $376.3 million for Q4 2025 at Neogenomics, down from $382.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $942.7 million in Q1 2021 and bottomed at $376.3 million in Q4 2025.
  • Average Current Assets over 5 years is $598.1 million, with a median of $593.1 million recorded in 2024.
  • The sharpest move saw Current Assets soared 337.58% in 2021, then plummeted 36.87% in 2025.
  • Year by year, Current Assets stood at $681.5 million in 2021, then dropped by 11.18% to $605.3 million in 2022, then dropped by 1.4% to $596.8 million in 2023, then dropped by 0.13% to $596.0 million in 2024, then tumbled by 36.87% to $376.3 million in 2025.
  • Business Quant data shows Current Assets for NEO at $376.3 million in Q4 2025, $382.5 million in Q3 2025, and $392.6 million in Q2 2025.